NPC-22
NPC-22-2
Phase 1 small_molecule completed
Quick answer
NPC-22 for Safety and Pharmacokinetics is a Phase 1 program (small_molecule) at Belpharma s.a. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Belpharma s.a.
- Indication
- Safety and Pharmacokinetics
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed